Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
作者信息
Duval X, Larger E, Longuet P, Leport C, Vilde J L
出版信息
Lancet. 2001 Feb 10;357(9254):475. doi: 10.1016/S0140-6736(05)71279-4.
Abstract
摘要
相似文献
1
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.溢乳、高泌乳素血症与蛋白酶抑制剂
Lancet. 2001 Feb 10;357(9254):475. doi: 10.1016/S0140-6736(05)71279-4.
2
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.溢乳、高催乳素血症与蛋白酶抑制剂
Lancet. 2001 Feb 10;357(9254):474; author reply 475. doi: 10.1016/S0140-6736(05)71276-9.
3
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.溢乳、高催乳素血症与蛋白酶抑制剂
Lancet. 2001 Feb 10;357(9254):473-4; author reply 475. doi: 10.1016/S0140-6736(05)71275-7.
4
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.溢乳、高泌乳素血症与蛋白酶抑制剂
Lancet. 2001 Feb 10;357(9254):474-5. doi: 10.1016/S0140-6736(05)71277-0.
5
Galactorrhoea and hyperprolactinaemia associated with protease-inhibitors.与蛋白酶抑制剂相关的溢乳和高泌乳素血症。
Lancet. 2000 Sep 16;356(9234):1003-4. doi: 10.1016/S0140-6736(00)02697-0.
6
Switching to nevirapine--results after one year.换用奈韦拉平——一年后的结果。
TreatmentUpdate. 2001 Aug;13(4):1-3.
7
Transfer therapy--Nevirapine for protease problems?转移疗法——奈韦拉平可解决蛋白酶问题？
TreatmentUpdate. 1999 Jun 1;11(4):6-7.
8
Galactorrhoea and hyperprolactinemia associated with HIV postexposure chemoprophylaxis.与HIV暴露后化学预防相关的溢乳和高泌乳素血症。
AIDS. 2002 Jun 14;16(9):1306-7. doi: 10.1097/00002030-200206140-00022.
9
Viramune cleared for use in combination with protease inhibitors.维乐命已获批与蛋白酶抑制剂联合使用。
AIDS Patient Care STDS. 1998 Nov;12(11):872.
10
Substitution for protease inhibitors in HIV therapy.艾滋病病毒治疗中蛋白酶抑制剂的替代疗法。
N Engl J Med. 2003 Dec 18;349(25):2460-1; author reply 2460-1. doi: 10.1056/NEJM200312183492516.
Zotero 插件